Y-mAbs Therapeutics falls after CFO steps down

Y-mAbs Therapeutics

14/03/2024 14:36

** Shares of drugmaker Y-mAbs Therapeutics  YMAB.O  fall 6%
to $14.88 
    ** Co announces resignation of Chief Financial Officer Bo
Kruse, who has been in the role since its founding in April 2015
    ** YMAB has begun a search process for a successor 
    ** Kruse will remain in the CFO role until his successor is
identified - YMAB
    ** Including session moves, the stock has more than doubled
in the last 12 months 

 (Reporting by Sneha S K in Bengaluru)
 ((Sneha.SK@thomsonreuters.com;))